Healthcare Innovation Related Content

Our vision at Glooko is to be the foundation for decision making in diabetes care, improving quality of life for people with diabetes.

With Bioquell, an Ecolab Solution, leading companies trust in our end-to-end contamination control solutions. Take the lead.

Researchers from the University of North Carolina and NC State have developed artificial beta cells that automatically release insulin into the bloodstream when glucose levels rise, leading the way for new diabetes treatment.

Here, Business Development Director at Aire Logic, Rob Hurrell, explains how COVID-19 has helped us all to become agile and deliver better digital health solutions, faster.

Professor Heather Sheardown, leader of Innovation Hub C20/20, discusses their research, innovation, and development of new biomaterials-based technologies to treat a variety of disorders in the eye.

Genevieve Leveille, CEO of UK firm 08 Group and Co-Chair of the TechUK DLT Working Group, collaborates with digital health tech companies to deliver verified-safe China-sourced Covid-19 test kits at scale.

Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.

Susan Bunn, Inform Health, discusses how technology can enable access to sexual health provision during COVID-19 and beyond.

Director of Product Management at Bioquell, Guy Turner, explains how RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, thus providing a 6-log sporicidal kill and eliminating all traces of COVID-19.

Professor L. Maximilian Buja of McGovern Medical School discusses medial education, it's advances and his experience in the field.

ImotopesTM: a radically new approach to the treatment of autoimmune diseases – now entering Ph.2 testing in type 1 diabetes.

Senior Accessibility Analyst at Digital Analyst Centre Mike Taylor discusses maximising technology to be both usable and accessible, and how to make it work for everyone.

The Intellin® platform has been created to fully understand diabetes needs, simplify remote self-management and identify risk of developing complications.

In response to the COVID-19 health crisis, Rajant Corporation, has capitalised on its in-house manufacturing and provided essential protective free-of-charge face masks to aid the valiant efforts of healthcare workers.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group shines the spotlight on dementia in the digital era, from a Hong Kong perspective.

Carlos Pinheiro, Principal Data Scientist, SAS, explores at mobility tracing as a more effective and safer alternative to contact tracing, one which would allow for lockdown measures to be eased more gradually.

Prof D. Chen-Yi Lee from the Department of Electronics Engineering at National Chiao Tung University in Taiwan, provides fascinating details about the project Toward Mobile Health-Care with Medical-IoT Devices.

Here, the International Agency for Research on Cancer and other experts provide an in-depth analysis of cancer, the second leading cause of death after cardiovascular diseases plus the role of technology and innovation in the field.

Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.

John H. Breen, political scientist and advisor, explains the humanitarian necessity of a multilateral response to COVID-19 and offers policy suggestions.